Victoria Drake Carnein

Upstream Process Development Scientist I at Alexion AstraZeneca Rare Disease

Speaker

Victoria Drake Carnein is a scientist in upstream process development at Alexion, AstraZeneca Rare Disease. She has expertise in cell culture, cell clarification, bioreactor automation, and data analytics. Victoria has experience leading the development of upstream cell culture processes during early and late stages of process development. She has a BSE in Chemical Engineering from the University of Connecticut and an MSE in Chemical and Biological Engineering from Princeton University.